Gastroenterology

Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses




Human studies examining associations between circulating levels of insulin-like growth factor 1 (IGF1) and insulin-like growth factor binding protein 3 (IGFBP3) and colorectal cancer risk have reported inconsistent results. We conducted complementary serologic and Mendelian randomization (MR) analyses to determine whether alterations in circulating levels of IGF1 or IGFBP3 are associated with colorectal cancer development.

Source link




Related posts

Morning Break: The 'Next Big Thing'; Diuretic Recall; OHSU Suspends Heart Transplants

Newsemia

BRCA Testing Recs; Antibiotics and Cancer: It's PodMed Double T!

Newsemia

Neuronal programming by microbiota regulates intestinal physiology

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy